2-溴-5-氟苯甲酸甲酯 | 6942-39-8

• 物质功能分类: 有机原料 - 有机氟化合物 - 氟苯甲酸系列
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-溴-5-氟苯甲酸甲酯
• 英文名称: methyl 2-bromo-5-fluorobenzoate
• 英文别名: 2-bromo-5-fluorobenzoic acid methyl ester
• CAS: 6942-39-8
• 化学式: C₈H₆BrFO₂
• mdl: MFCD00086167
• 分子量: 233.037
• InChiKey: FCMQMRAFVRTHCR-UHFFFAOYSA-N

物化性质

• 沸点：
  247.5±25.0 °C(Predicted)
• 密度：
  1.577±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.125
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 危险品标志：
  Xi
• 海关编码：
  2916399090
• 储存条件：
  | 室温 |

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Methyl 2-bromo-5-fluorobenzoate
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Methyl 2-bromo-5-fluorobenzoate
CAS number: 6942-39-8

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H6BrFO2
Molecular weight: 233.0

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen fluoride, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-溴-5-氟苯甲酸甲酯 在 三氟化硼乙醚 、 sodium hexamethyldisilazane 作用下， 以 四氢呋喃 、 乙二醇 为溶剂， 反应 6.33h， 生成 2-[1-(2-bromo-5-fluorophenyl)-2-(2-fluorophenyl)ethylidene]hydrazinecarboximidamide
  参考文献：
  名称：

  Substituted annellated pyrimidines and use thereof

  摘要：

  本申请涉及新型取代的螺合嘧啶类化合物，其生产方法，单独或组合使用用于治疗和/或预防疾病以及用于生产治疗和/或预防疾病的药物产品的用途，特别是用于治疗和/或预防心血管疾病。

  公开号：

  US20130338137A1
• 作为产物：
  描述：

  2-溴-5-氟苯甲酸 在 草酰氯 、 三乙胺 、 N,N-二甲基甲酰胺 作用下， 以 二氯甲烷 为溶剂， 反应 3.17h， 生成 2-溴-5-氟苯甲酸甲酯
  参考文献：
  名称：

  N-杂环卡宾催化的酰胺远程 C(sp3)-H 酰化

  摘要：

  通过自由基介导的 1,5-氢原子转移 (HAT) 机制开发了N-杂环卡宾催化的邻烷基苯甲酰胺的苄基 C-H 酰化和级联环化。与光氧化还原催化不同，这种无光方法能够通过 Breslow 烯醇化物通过单电子转移 (SET) 产生酰胺基自由基。温和的过程可容忍大多数常见的官能团，并以中等到高的收率提供各种二氢异喹啉酮。芳氧基酰胺的电化学特性与基态 SET 假设一致，并提出了一种可能的有机催化转化机制。

  DOI：

  10.1016/j.tetlet.2023.154483

文献信息

• [EN] DISUBSTITUTED OCTAHY-DROPYRROLO [3,4-C] PYRROLES AS OREXIN RECEPTOR MODULATORS<br/>[FR] OCTAHYDROPYRROLO [3,4-C] PYRROLES DISUBSTITUÉS UTILISÉS COMME MODULATEURS DU RÉCEPTEUR DE L'OREXINE
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2012145581A1

  公开（公告）日：2012-10-26

  Disubstituted octahydropyrrolo[3,4-c]pyrrole compounds are described, which are useful as orexin receptor modulators. Such compounds may be useful in pharmaceutical compositions and methods for the treatment of diseased states, disorders, and conditions mediated by orexin activity, such as insomnia.

  描述了二取代的八氢吡咯[3,4-c]吡咯化合物，这些化合物可用作促进睡眠素受体的调节剂。这些化合物可能在药物组合物和治疗由促进睡眠素活性介导的疾病状态、紊乱和病况的方法中有用，比如失眠。
• [EN] 2-CYANOISOINDOLINE DERIVATIVES FOR TREATING CANCER<br/>[FR] DÉRIVÉS DE 2-CYANOISOINDOLINE POUR LE TRAITEMENT DU CANCER
  申请人：MISSION THERAPEUTICS LTD

  公开号：WO2017158388A1

  公开（公告）日：2017-09-21

  The invention relates to novel compounds of formula I which are inhibitors of deubiquitylating enzymes (DUBs) and/or desumoylating enzymes. In particular, the invention relates to the inhibition of ubiquitin C-terminal hydrolase 7 or ubiquitin specific peptidase 7 (USP7). The invention further relates to methods for the preparation of these compounds and to their use in the treatment of cancer.

  这项发明涉及公式I的新化合物，这些化合物是去泛素化酶（DUBs）和/或去泛素化酶的抑制剂。具体来说，该发明涉及抑制泛素C端水解酶7或泛素特异性肽酶7（USP7）。该发明还涉及这些化合物的制备方法以及它们在癌症治疗中的应用。
• Discovery of Soticlestat, a Potent and Selective Inhibitor for Cholesterol 24-Hydroxylase (CH24H)
  作者：Tatsuki Koike、Masato Yoshikawa、Haruhi Kamisaki Ando、William Farnaby、Toshiya Nishi、Etsurou Watanabe、Jason Yano、Maki Miyamoto、Shigeru Kondo、Tsuyoshi Ishii、Takanobu Kuroita

  DOI：10.1021/acs.jmedchem.1c00864

  日期：2021.8.26

  to 24S-hydroxycholesterol (24HC). Despite a wide range of potential of CH24H as a drug target, no potent and selective inhibitors have been identified. Here, we report on the structure-based drug design (SBDD) of novel 4-arylpyridine derivatives based on the X-ray co-crystal structure of hit derivative 1b. Optimization of 4-arylpyridine derivatives led us to identify 3v ((4-benzyl-4-hydroxypiperidin-1-yl)(2

  胆固醇24-羟化酶（CH24H，CYP46A1）是一种大脑特异性细胞色素P450（CYP）家族酶，通过将胆固醇转化为24S-羟基胆固醇（24HC），在脑胆固醇稳态中发挥作用。尽管 CH24H 作为药物靶点具有广泛的潜力，但尚未发现有效的选择性抑制剂。在这里，我们报告了基于hit衍生物1b的X射线共晶结构的新型4-芳基吡啶衍生物的基于结构的药物设计（SBDD）。 4-芳基吡啶衍生物的优化使我们确定3v ((4-benzyl-4-羟基哌啶-1-基)(2,4'-联吡啶-3-基)甲酮，IC 50 = 7.4 nM) 是一种高效、选择性、脑渗透性 CH24H 抑制剂。小鼠口服3v后，大脑中 24HC 水平呈剂量依赖性降低（1、3 和 10 mg/kg）。化合物3v （soticlestat，也称为 TAK-935）目前正在临床研究中，作为治疗癫痫的新型药物类别，用于治疗 Dravet 综合征和 Lennox-Gastaut
• Hypervalent Iodine-Mediated Intramolecular <i>trans</i>-Aminocarboxylation and Oxoaminocarboxylation of Alkynes: Divergent Cascade Annulations of Isocoumarins under Metal-Free Conditions
  作者：Xiang Zhang、Wenjuan Hou、Daisy Zhang-Negrerie、Kang Zhao、Yunfei Du

  DOI：10.1021/acs.orglett.5b02611

  日期：2015.11.6

  An exclusive trans-aminocarboxylation and oxoaminocarboxylation of diarylalkynes were realized through hypervalent iodine-mediated cascade annulations under metal-free conditions, leading to divergent assembly of fused or spiro polycyclic heterocycles with a dosage of the hypervalent iodine oxidant. The mechanisms for the formation of both products are proposed.

  二芳基炔烃的排他性反氨基氨基化和氧氨基羧基化是通过在无金属条件下通过高价碘介导的级联环化实现的，从而导致稠合或螺环多环杂环与不同剂量的高价碘氧化剂发生发散组装。提出了两种产物形成的机理。
• Construction of 1,4-Benzodiazepine Skeleton from 2-(Arylamino)benzamides through PhI(OAc)₂-Mediated Oxidative C–N Bond Formation
  作者：Xuming Li、Liu Yang、Xiang Zhang、Daisy Zhang-Negrerie、Yunfei Du、Kang Zhao

  DOI：10.1021/jo402413g

  日期：2014.2.7

  the biologically important 1,4-benzodiazepine skeleton were conveniently constructed from 2-(arylamino)benzamides through PhI(OAc)2-mediated oxidative C–N bond formation. The attractive features of this new synthetic strategy include mild reaction conditions, the heavy-metal-free characteristic of the oxidative coupling process, and the flexibility to tolerate a broad scope of substrates.

  由2-（芳基氨基）苯甲酰胺通过PhI（OAc）2介导的氧化性C–N键形成，可方便地构建涉及具有重要生物学意义的1,4-苯并二氮杂skeleton骨架的新化合物。这种新的合成策略的吸引人的特征包括温和的反应条件，氧化偶联过程的不含重金属的特性以及可耐受广泛范围底物的灵活性。

表征谱图